Acetaldehyde and defective mismatch repair increase colonic tumours in a Lynch syndrome model with Aldh1b1 inactivation
Disease Models & Mechanisms · 01.08.2023 · 16 (8)
DOI: 10.1242/dmm.050240 ↗Kurz gefasst
Fachartikel in der Zeitschrift Disease Models & Mechanisms, online erschienen am 31.07.2023. Verfasst von Guia Cerretelli und 4 weiteren Autor:innen. Beteiligte Einrichtung: University of Edinburgh, Division of Pathology, Centre for Comparative Pathology, CRUK Edinburgh Centre, Institute of Genetics and Cancer, Western Ge…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Hereditary Nonpolyposis, Colorectal Neoplasms, Colonic Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pathological Society of Great Britain and Ireland, University of Edinburgh.
Abstract (Originalsprache)
ALDH1B1 expressed in the intestinal epithelium metabolises acetaldehyde to acetate, protecting against acetaldehyde-induced DNA damage. MSH2 is a key component of the DNA mismatch repair (MMR) pathway involved in Lynch syndrome (LS)-associated colorectal cancers. Here, we show that defective MMR (dMMR) interacts with acetaldehyde, in a gene/environment interaction, enhancing dMMR-driven colonic tumour formation in a LS murine model of Msh2 conditional inactivation (Lgr5-CreER; Msh2flox/−, or Msh2-LS) combined with Aldh1b1 inactivation. Conditional (Aldh1b1flox/flox) or constitutive (Aldh1b1−/−) Aldh1b1 knockout alleles combined with the conditional Msh2flox/− intestinal knockout mouse model of LS (Msh2-LS) received either ethanol, which is metabolised to acetaldehyde, or water. We demonstrated that 41.7% of ethanol-treated Aldh1b1flox/flox Msh2-LS mice and 66.7% of Aldh1b1−/− Msh2-LS mice developed colonic epithelial hyperproliferation and adenoma formation, in 4.5 and 6 months, respectively, significantly greater than 0% in water-treated control mice. Significantly higher numbers of dMMR colonic crypt foci precursors and increased plasma acetaldehyde levels were observed in ethanol-treated Aldh1b1flox/flox Msh2-LS and Aldh1b1−/− Msh2-LS mice compared with those in water-treated controls. Hence, ALDH1B1 loss increases acetaldehyde levels and DNA damage that interacts with dMMR to accelerate colonic, but not small intestinal, tumour formation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Edinburgh, Division of Pathology, Centre for Comparative Pathology, CRUK Edinburgh Centre, Institute of Genetics and Cancer, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK.
- Wellcome Sanger Institute, Hinxton, Cambridge CB10 1HH, UK.
ORCID-Profile: David J Adams, Mark J Arends
Förderung
- Pathological Society of Great Britain and Ireland
- University of Edinburgh
Zitieren
APA
Cerretelli, G., Zhou, Y., Müller, M. F., Adams, D. J., & Arends, M. J. (2023). Acetaldehyde and defective mismatch repair increase colonic tumours in a Lynch syndrome model with Aldh1b1 inactivation. Disease Models & Mechanisms, 16(8). https://doi.org/10.1242/dmm.050240
Vancouver
Cerretelli G, Zhou Y, Müller MF, Adams DJ, Arends MJ. Acetaldehyde and defective mismatch repair increase colonic tumours in a Lynch syndrome model with Aldh1b1 inactivation. Disease Models & Mechanisms. 2023;16(8). doi:10.1242/dmm.050240
BibTeX
@article{Cerretelli2023,
author = {Cerretelli, Guia and Zhou, Ying and Müller, Mike F and Adams, David J and Arends, Mark J},
title = {Acetaldehyde and defective mismatch repair increase colonic tumours in a Lynch syndrome model with Aldh1b1 inactivation},
journal = {Disease Models & Mechanisms},
year = {2023},
volume = {16},
number = {8},
doi = {10.1242/dmm.050240}
}
EUVIMED